Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypersensitivity reactions induced by etoposide.

P J O'Dwyer, R B Weiss

    Cancer Treatment Reports
    |July 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Hypersensitivity reactions to etoposide can occur. Some patients were successfully re-treated with etoposide after premedication, suggesting a manageable acute toxicity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial.

    NPJ precision oncology·2022
    Same author

    Long term outcome and elasticity of a polyester mesh used for laparoscopic ventral hernia repair.

    Hernia : the journal of hernias and abdominal wall surgery·2021
    Same author

    Corrigendum to 'Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q': [Annals of Oncology 30 (2019) 1821-1830].

    Annals of oncology : official journal of the European Society for Medical Oncology·2021
    Same author

    Subcutaneous and visceral adipose tissue in patients with primary and recurrent incisional hernia.

    Hernia : the journal of hernias and abdominal wall surgery·2021
    Same author

    Letter to the Editor Re: Evaluation of appendicitis risk prediction model in adults with suspected appendicitis.

    The British journal of surgery·2021
    Same author

    Radiology teaching improves Anatomy scores for medical students.

    The British journal of radiology·2020
    Same journal

    Rhabdomyolysis associated with high-dose cytarabine.

    Cancer treatment reports·1987
    Same journal

    Acute laryngeal edema after single-dose irradiation and doxorubicin.

    Cancer treatment reports·1987
    Same journal

    Timing may be a critical factor in drug therapy.

    Cancer treatment reports·1987
    Same journal

    Prednimustine in advanced malignant melanoma: a phase II study.

    Cancer treatment reports·1987
    Same journal

    Phase II evaluation of diaziquone in pancreatic carcinoma: a Southwest Oncology Group Study.

    Cancer treatment reports·1987
    Same journal

    Teniposide in metastatic renal and bladder cancer: a Southwest Oncology Group Study.

    Cancer treatment reports·1987
    See all related articles

    Area of Science:

    • Oncology
    • Clinical Pharmacology

    Background:

    • Etoposide is a widely used chemotherapy agent.
    • Hypersensitivity reactions to etoposide are an emerging concern.

    Purpose of the Study:

    • To report on patients experiencing hypersensitivity to etoposide.
    • To detail clinical characteristics and outcomes of these patients.
    • To explore potential management strategies for etoposide hypersensitivity.

    Main Methods:

    • Case series reporting on eight patients with etoposide hypersensitivity.
    • Clinical data collection on patient characteristics and treatment outcomes.
    • Analysis of re-treatment strategies, including premedication.

    Main Results:

    Related Experiment Videos

  • Eight patients with hypersensitivity to etoposide were identified.
  • Four patients received treatment to manage hypersensitivity symptoms.
  • Two patients were successfully re-treated with etoposide after premedication with diphenhydramine and hydrocortisone.

    • Conclusions:

    • Hypersensitivity to etoposide is recognized as an occasional acute toxicity.
    • Premedication may allow for successful re-treatment in some hypersensitive patients.
    • The precise mechanism of etoposide-induced hypersensitivity requires further investigation.